LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, announced today that it has initiated an operational, technical, and commercial evaluation process to potentially integrate installment-based healthcare payment capabilities through Cashea, a leading buy-now-pay-later financial technology platform in Venezuela. The proposed initiative aims to reduce upfront financial barriers for patients seeking access to private healthcare services, including consultations, diagnostics, wellness programs, and other eligible offerings within the LataMed AI ecosystem.
Management believes that improving payment accessibility could support greater patient engagement, increased healthcare utilization, and stronger platform adoption. By addressing affordability challenges, the company hopes to strengthen its position as a technology-enabled healthcare marketplace serving patients, providers, and healthcare partners throughout Latin America. Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: 'We believe financial accessibility is a critical component of healthcare delivery. Our objective is to evaluate solutions that may help patients obtain timely medical care while simultaneously expanding the reach and utility of our healthcare ecosystem.'
The potential integration aligns with LataMed AI's broader strategy of combining artificial intelligence, telehealth infrastructure, care coordination tools, and digital payment accessibility to create a more scalable healthcare marketplace. However, the company has not entered into a definitive commercial agreement as of the date of this release. Completion of any integration remains subject to further commercial discussions, technical implementation requirements, regulatory review, and customary business conditions.
This news is significant because it addresses a critical barrier to healthcare access in emerging markets: affordability. In many Latin American countries, private healthcare services are often out of reach for a large portion of the population due to high upfront costs. By enabling installment payments, LataMed AI could potentially democratize access to private healthcare, allowing patients to receive timely medical care without the burden of immediate full payment. This could lead to earlier diagnosis and treatment, improved health outcomes, and reduced strain on public health systems.
For the healthcare industry, this move signals a growing trend of integrating fintech solutions into healthcare delivery. The partnership between a telehealth company and a buy-now-pay-later platform could set a precedent for other digital health firms in emerging markets, encouraging them to adopt similar payment flexibility to attract and retain patients. For patients, it means more options to manage healthcare expenses, potentially increasing their willingness to seek preventive care and follow treatment plans.
LataMed AI intends to provide additional updates as material developments occur. For more information, visit https://latamed.ai or review the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
